Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

About this update from Haemonetics Corporation

Financial release and supplemental presentation accessible online BOSTON , May 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal year 2026, which ended March 28, 2026, are available on the Company's Investor Relations website at www.haemonetics.com . The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 7, 2026. Conference Call and Webcast Information: A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on May 7, 2026 and will remain accessible for one year via the webcast link above. Earnings Materials: Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast: ABOUT HAEMONETICS Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com . Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury (781) 356-9763 [email protected] David Trenk, Manager-Investor Relations (203) 733-4987 [email protected] Media Contact: Josh Gitelson, Sr. Director-Global Communications  (781) 356-9776 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-fourth-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302764893.html

View stock analysis, news, and events for Haemonetics Corporation